Perimenopause and Insulin Resistance: Why Your Blood Sugar Changes in Your 40s

Introduction

Something shifts in your 40s that nobody adequately warns you about.

You are eating the way you always have. Your exercise habits have not dramatically changed. And yet your body is responding differently - weight is accumulating around your middle in a way it never did before, your energy is less reliable, and the afternoon slump that used to be manageable now feels genuinely disruptive.

You might be blaming yourself. Assuming you need to try harder, eat less, exercise more.

But there is a specific biological reason your body is behaving this way - and it has nothing to do with effort or discipline.

As oestrogen declines in perimenopause, insulin sensitivity declines with it. Your body becomes less efficient at managing blood sugar - not because of what you are eating, but because of a hormonal shift that is removing one of oestrogen's most important metabolic functions.

Understanding this changes everything about how you approach your health in this decade.

What Insulin Resistance Actually Means

Before getting into the perimenopause connection, it helps to understand what insulin resistance actually is - because it is one of those clinical terms that gets used a lot without being clearly explained.

Insulin is the hormone that allows glucose - the sugar circulating in your bloodstream after you eat - to enter your cells and be used for energy. When cells are sensitive to insulin, this process is efficient: glucose enters cells readily, blood sugar stabilises quickly after meals, and relatively modest amounts of insulin are required to get the job done.

When cells become resistant to insulin, this process becomes less efficient. The same amount of insulin no longer produces the same effect. The body compensates by producing more - maintaining blood sugar control, but at the cost of chronically elevated insulin levels circulating throughout the body.

Those chronically elevated insulin levels have consequences that go well beyond blood sugar - driving fat storage, stimulating hormone production, promoting inflammation, and creating the energy instability that makes daily life feel harder than it should.

For the foundational explanation of how insulin resistance drives symptoms across the body: Signs of Silent Insulin Resistance in Women

The Oestrogen–Insulin Connection

Here is the part that most women in perimenopause have never been told - and that explains so much of what they are experiencing.

Oestrogen is not just a reproductive hormone. It is a metabolic hormone with direct insulin-sensitising effects throughout the body.

Throughout your reproductive years, oestrogen has been quietly supporting your metabolic health in several specific ways:

• It supports GLUT4 transporter activity. GLUT4 transporters are the proteins that move to the surface of muscle cells and fat cells in response to insulin, opening the door for glucose to enter. Oestrogen upregulates GLUT4 expression - meaning your cells have more of these transporters available and respond more readily to insulin's signal.
• It supports insulin receptor sensitivity. Oestrogen directly enhances the sensitivity of insulin receptors on cell surfaces, making the insulin signalling cascade more efficient from the moment insulin binds.
• It supports mitochondrial function. Mitochondria - the energy-producing structures within cells - rely on oestrogen for optimal glucose metabolism. Oestrogen supports the efficiency with which cells convert glucose into usable energy rather than storing it as fat.
• It reduces hepatic glucose output. The liver produces and releases glucose into the bloodstream - a process called gluconeogenesis - and oestrogen partially suppresses this, reducing the baseline glucose load the body needs to manage.

As oestrogen declines in perimenopause, all of these insulin-sensitising effects are progressively withdrawn. The result is measurable, clinically documented worsening of insulin sensitivity - independent of diet, independent of exercise, independent of any lifestyle factor.¹

This is not a metaphor or a generalisation. It is a direct physiological mechanism with measurable consequences.

The blood sugar and metabolic changes many women experience in their 40s are not primarily caused by eating differently or moving less. They are caused by the withdrawal of oestrogen's insulin-sensitising effects - a hormonal change that would alter metabolic function regardless of how carefully you were eating. This distinction matters enormously. It removes the self-blame, and it points toward the interventions that will actually help.

What This Looks Like in Daily Life

The clinical reality of perimenopausal insulin resistance translates into a very specific daily experience that many women recognise immediately when it is described.

Food that used to feel fine now produces different responses. The bowl of porridge that was a perfectly reasonable breakfast at 35 now produces an energy crash by mid-morning at 45. The pasta dinner that felt neutral before now triggers afternoon fatigue the following day. The same food, a different metabolic response - because the hormonal environment in which your body is processing that food has changed.

Abdominal weight that was not there before. As insulin resistance worsens, the body preferentially stores fat in visceral and abdominal depots - driven by the interaction of elevated insulin, declining oestrogen, and rising cortisol reactivity. This is not the same as general weight gain. It is a hormonally directed shift in where and how your body stores energy.

Energy that is harder to sustain. When cells are not absorbing glucose efficiently, the brain and body receive less stable energy - producing the fatigue, afternoon crashes, and reliance on caffeine and sugar that are so characteristic of insulin-resistant physiology.

Cravings that feel driven rather than chosen. Blood sugar instability creates physiological urgency around food - particularly carbohydrates and sugar - as the body attempts to quickly correct low glucose. These are not weakness. They are a metabolic signal.

Weight loss that simply does not respond the way it used to. Chronically elevated insulin actively promotes fat storage and impairs fat breakdown. Eating in a caloric deficit while insulin is high is working against a significant hormonal headwind.

The Compounding Factors

Oestrogen withdrawal is the primary driver of worsening insulin sensitivity in perimenopause - but it does not operate alone. Several additional changes in this decade compound the metabolic picture.

Declining Muscle Mass

Oestrogen and progesterone both support muscle protein synthesis - they help maintain lean muscle mass throughout the reproductive years. As both hormones decline, muscle mass begins to decrease - accelerating the age-related muscle loss that would occur slowly regardless.

This matters metabolically because skeletal muscle is the primary site of insulin-mediated glucose disposal. Less muscle mass means less capacity to absorb glucose from the bloodstream, directly worsening insulin resistance.

This is one of the most important reasons resistance training becomes a non-negotiable metabolic priority in perimenopause - not for aesthetic reasons, but as a direct insulin-sensitising intervention. More on this in Perimenopause and Metabolism: The Complete Guide

Rising Cortisol Reactivity

Oestrogen has a buffering effect on the HPA axis - it moderates cortisol responses to stress and supports the return to baseline after a stressor. As oestrogen declines, this buffer is removed. Cortisol responses become larger and last longer.

Cortisol raises blood glucose through gluconeogenesis - the liver manufacturing and releasing glucose in response to stress. For a woman with already-worsening insulin sensitivity, each cortisol spike is an additional blood glucose load that the compromised insulin system has to manage.

The result is blood sugar instability that occurs not just in response to food, but in response to stress, poor sleep, and the cortisol cycling that is a feature of daily perimenopausal life.

For the full detail on cortisol in perimenopause: Perimenopause and Cortisol: Why Stress Hits Harder in Midlife

Poor Sleep

Sleep deprivation - even partial sleep restriction - measurably reduces insulin sensitivity within a single night. As detailed in PCOS and Sleep, the mechanisms are direct: poor sleep raises cortisol, elevates inflammatory markers, disrupts the appetite hormones ghrelin and leptin, and impairs cellular glucose uptake.

In perimenopause, where sleep disruption is extremely common - driven by night sweats, progesterone withdrawal, and HPA axis changes - this sleep-driven worsening of insulin sensitivity adds to the hormonal worsening that is already occurring. The two feed each other: poor sleep worsens insulin resistance, and insulin resistance worsens sleep quality.

Perimenopause and Sleep

Chronic Inflammation

Oestrogen has direct anti-inflammatory effects. Its decline in perimenopause removes this protection, allowing inflammatory load to rise - driven additionally by the visceral fat accumulation that is itself a consequence of worsening insulin resistance.

Chronic inflammation directly impairs insulin receptor signalling - the same cytokines elevated in perimenopause interfere with the cellular machinery that makes insulin work. This creates another self-reinforcing loop: insulin resistance drives inflammation, inflammation worsens insulin resistance.

Why This Matters Beyond Symptoms

The metabolic changes of perimenopause are not just uncomfortable. They have long-term clinical consequences that are worth understanding - not to create alarm, but to provide genuine motivation for addressing them actively rather than passively.

Type 2 diabetes risk increases significantly around and after menopause. Women who enter the transition with pre-existing insulin resistance - from PCOS, metabolic syndrome, or long-standing dietary patterns - are at meaningfully elevated risk of progressing to impaired glucose tolerance or type 2 diabetes in the perimenopausal and early post-menopausal years.²

Cardiovascular risk rises as the lipid profile shifts with worsening insulin resistance - triglycerides rise, HDL falls, and LDL particle quality worsens. Combined with the loss of oestrogen's direct cardioprotective vascular effects, the cardiovascular risk profile in post-menopausal women rises significantly compared to premenopausal years.

Cognitive health is influenced by insulin resistance - the brain is an insulin-sensitive organ, and impaired brain glucose metabolism is increasingly understood as a contributor to cognitive decline risk over the long term.

The quality of metabolic management through this decade directly shapes these long-term outcomes. Active management is not just about feeling better now. It is an investment in the decades that follow.

If you have not had fasting insulin measured - not just fasting glucose or HbA1c - it is worth requesting specifically. Fasting glucose and HbA1c can remain normal for years while fasting insulin is significantly elevated, meaning insulin resistance is present and progressing without any standard screening test flagging it.

What Actually Helps: Managing Insulin Resistance in Perimenopause

The practical good news is that insulin sensitivity is responsive - it is not a fixed state, and meaningful improvement is achievable at any point in the transition.

Dietary Blood Sugar Management

The most direct lever available is building a dietary pattern that reduces the insulin demand placed on an already less-efficient system. This does not mean a restrictive or complicated approach. It means making structural changes to how meals are built.

In practice:

• Lead every meal with protein and healthy fat - these slow glucose absorption and reduce the post-meal insulin spike
• Choose lower-glycaemic carbohydrate sources - non-starchy vegetables, legumes, wholegrains - over refined carbohydrates and sugars
• Never eat carbohydrates in isolation - always pair with protein, fat, or fibre
• Eat within an hour of waking - skipping breakfast extends the overnight cortisol response and sets up blood sugar instability for the rest of the day
• A short walk after meals - even 10 minutes - measurably reduces post-meal glucose response

For the full dietary framework relevant to this: Best Diet for PCOS and Insulin Resistance - the principles apply equally in perimenopause.

Resistance Training

Building and preserving muscle mass is the most powerful long-term insulin sensitising strategy available in perimenopause. Muscle cells are the primary site of insulin-mediated glucose disposal - more muscle means more capacity for glucose absorption, lower insulin demand, and better blood sugar regulation.

Two to four resistance training sessions per week, with progressive challenge over time, produces measurable improvements in insulin sensitivity within weeks and cumulative benefits over months.

Sleep as a Metabolic Intervention

Consistently prioritising sleep quality - not just quantity - is a direct insulin-sensitising strategy. Addressing the specific drivers of perimenopausal sleep disruption (vasomotor symptoms, cortisol management, blood sugar stability overnight) produces metabolic benefits that extend well beyond feeling more rested.

Targeted Supplementation

Several supplements have specific evidence for supporting insulin sensitivity in the context of perimenopause and hormonal change:

Magnesium glycinate - supports insulin receptor function and is commonly depleted in insulin-resistant individuals.

Inositol - well-evidenced for insulin sensitisation, with the same mechanisms relevant in perimenopause as in PCOS.

Omega-3 fatty acids - reduce the inflammatory load that impairs insulin signalling.

Berberine - evidence for insulin sensitisation comparable to metformin in several trials. Worth discussing with a clinician if dietary and lifestyle approaches alone are insufficient.

For the complete supplement guide: Perimenopause Supplements: What the Evidence Says

Consider Whether HRT Is Relevant

Body-identical oestrogen replacement directly restores some of the insulin-sensitising effects withdrawn by oestrogen decline. Clinical studies show that oestradiol - particularly transdermal (patch or gel) administration, which avoids the liver's first-pass metabolism - meaningfully improves insulin sensitivity and reduces the rate of visceral fat accumulation in perimenopausal women.³

For women with significant metabolic disruption in perimenopause, HRT is not just a symptom management tool. It is a metabolic intervention. The conversation with a knowledgeable clinician is worth having.

The Bottom Line

The blood sugar changes and metabolic shifts you are experiencing in your 40s are not your fault and they are not primarily caused by what you are eating. They are a direct consequence of declining oestrogen withdrawing the insulin-sensitising support it has provided throughout your reproductive years.

Understanding that mechanism changes the approach - away from caloric restriction and willpower, toward targeted strategies that directly support insulin sensitivity in the context of a changed hormonal environment.

Dietary structure, resistance training, sleep quality, cortisol management, targeted supplementation, and a clinical conversation about HRT are all legitimate levers. Used together, they produce meaningful improvements in insulin sensitivity, body composition, energy, and long-term metabolic health.

Your body is not failing you. It is responding to a real hormonal change - and it responds to the right metabolic support.

Want a Personalised Approach to Your Perimenopausal Metabolic Health?

In clinical practice, I assess the full metabolic picture - including the insulin resistance, inflammatory load, and hormonal changes that shift in perimenopause - and build a clinical approach that addresses your individual situation.

Our Metabolic Balance® programme uses your blood chemistry to design a personalised nutrition protocol that recalibrates insulin sensitivity and works with your changing hormonal environment - not against it.

👉 Book a Health Strategy Session

In-clinic and remote consultations available.

Free Resource - Start Here

The 7-Day Metabolic Reset is a free, structured guide covering blood sugar stabilisation, anti-inflammatory nutrition, and practical daily strategies - designed for women navigating metabolic changes through perimenopause and beyond.

👉 Download the 7-Day Metabolic Reset

References

1. Mauvais-Jarvis F, et al. (2013). The role of oestrogens in insulin resistance: a review. Trends in Endocrinology and Metabolism, 24(5), 251–258.
2. Soriguer F, et al. (2012). Incidence of type 2 diabetes in southern Spain. European Journal of Clinical Nutrition, 66(10), 1101–1106.
3. Lobo RA. (2017). Hormone-replacement therapy: current thinking. Nature Reviews Endocrinology, 13(4), 220–231.